UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3052) 3052
Newsletter (28) 28
Publication (6) 6
Book Chapter (5) 5
Magazine Article (3) 3
Dissertation (2) 2
Book / eBook (1) 1
Book Review (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1867) 1867
humans (1807) 1807
life sciences & biomedicine (1778) 1778
ceftriaxone (1464) 1464
ceftriaxone - pharmacology (1238) 1238
male (1044) 1044
pharmacology & pharmacy (1009) 1009
anti-bacterial agents - pharmacology (944) 944
microbial sensitivity tests (906) 906
female (894) 894
microbiology (821) 821
infectious diseases (731) 731
ceftriaxone - therapeutic use (724) 724
animals (589) 589
adult (565) 565
antibiotics (499) 499
middle aged (489) 489
anti-bacterial agents - therapeutic use (473) 473
aged (393) 393
ceftriaxone - administration & dosage (386) 386
cephalosporins - pharmacology (345) 345
research article (316) 316
drug resistance (303) 303
adolescent (292) 292
ceftriaxone sodium (291) 291
child (264) 264
cefotaxime - pharmacology (253) 253
child, preschool (246) 246
neisseria gonorrhoeae - drug effects (244) 244
cefotaxime - analogs & derivatives (235) 235
infant (229) 229
streptococcus pneumoniae - drug effects (220) 220
antimicrobial agents (215) 215
ceftriaxone - pharmacokinetics (214) 214
drug resistance, bacterial (213) 213
cephalosporins (209) 209
bacteria (202) 202
research (189) 189
rats (187) 187
anti-bacterial agents - administration & dosage (184) 184
antimicrobial resistance (184) 184
treatment outcome (174) 174
bacterial infections - drug therapy (173) 173
drug resistance, microbial (173) 173
ciprofloxacin (171) 171
drug resistance in microorganisms (164) 164
mice (164) 164
health aspects (163) 163
penicillins - pharmacology (161) 161
cephalosporins - therapeutic use (156) 156
ciprofloxacin - pharmacology (156) 156
medicine (152) 152
gonorrhea - microbiology (151) 151
aged, 80 and over (150) 150
escherichia coli - drug effects (149) 149
immunology (147) 147
bacteria - drug effects (146) 146
ceftriaxone - adverse effects (146) 146
pharmacology (143) 143
drug therapy (142) 142
analysis (141) 141
infections (140) 140
cefotaxime - therapeutic use (135) 135
penicillin (135) 135
disease models, animal (134) 134
drug therapy, combination (134) 134
gonorrhea - drug therapy (134) 134
hospitals (133) 133
neurosciences (130) 130
neurosciences & neurology (130) 130
neisseria gonorrhoeae - isolation & purification (128) 128
penicillin resistance (127) 127
oncology (124) 124
antibiotic resistance (123) 123
neisseria gonorrhoeae (122) 122
pneumonia (121) 121
injections, intravenous (120) 120
gonorrhea (119) 119
young adult (119) 119
time factors (118) 118
ampicillin (116) 116
azithromycin (116) 116
risk factors (116) 116
drug resistance, multiple, bacterial (115) 115
patients (113) 113
kinetics (112) 112
ceftriaxone - blood (109) 109
cefotaxime (108) 108
glutamate (108) 108
prospective studies (108) 108
neisseria gonorrhoeae - genetics (107) 107
public health (105) 105
cefotaxime - metabolism (104) 104
infant, newborn (103) 103
retrospective studies (103) 103
bacterial infections and mycoses (102) 102
epidemiology (101) 101
laboratories (101) 101
drug administration schedule (100) 100
pediatrics (100) 100
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2952) 2952
Japanese (104) 104
French (37) 37
Spanish (21) 21
Chinese (16) 16
Italian (15) 15
Turkish (13) 13
Russian (12) 12
Portuguese (9) 9
German (6) 6
Dutch (3) 3
Polish (3) 3
Romanian (3) 3
Hungarian (2) 2
Ukrainian (2) 2
Hebrew (1) 1
Lithuanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Clinical infectious diseases, ISSN 1537-6591, 09/2017, Volume 65, Issue 6, pp. 918 - 923
Background. The Centers for Disease Control and Prevention (CDC) currently recommends dual therapy with ceftriaxone and azithromycin for gonorrhea to ensure... 
Antimicrobial drug resistance | Gonorrhea | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Humans | Middle Aged | Ceftriaxone - pharmacology | Male | Neisseria gonorrhoeae - enzymology | Microbial Sensitivity Tests | Young Adult | Anti-Bacterial Agents - therapeutic use | Drug Resistance, Multiple, Bacterial | Adult | Female | beta-Lactamases - metabolism | Drug Therapy, Combination | Neisseria gonorrhoeae - genetics | Penicillins - pharmacology | Gonorrhea - microbiology | Neisseria gonorrhoeae - drug effects | Gonorrhea - transmission | Tetracycline - pharmacology | Ciprofloxacin - pharmacology | Hawaii | Gonorrhea - drug therapy | Azithromycin - pharmacology | Contact Tracing | Ceftriaxone - therapeutic use | Azithromycin - therapeutic use | Anti-Bacterial Agents - pharmacology | Drug resistance in microorganisms | Neisseria gonorrhoeae | Patient outcomes | Azithromycin | Reports | Ceftriaxone sodium | Dosage and administration | Research | Ceftriaxone | Therapy | Sexually transmitted diseases--STD | Level (quantity) | Genomic analysis | Genomics | Agar | Drug resistance | Disease control | Patients | Antiinfectives and antibacterials | Dilution | Antibiotics | Cephalosporins | Penicillin | Clusters | Antimicrobial resistance | Ciprofloxacin | Index Medicus | antimicrobial drug resistance | gonorrhea
Journal Article
Journal Article